|Age:||18 - 75 years|
|Keywords:||NASH, Fatty liver, Nonalcoholic Steatohepatitis, RESOLVE-IT|
|Type:||Phase 3, Drug study|
This study will last up to 6 years. If eligible, the study involves three phases:
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.